AA
CRL icon

Ancora Advisors’s Charles River Laboratories CRL Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$8.65K Buy
57
+1
+2% +$152 ﹤0.01% 1385
2025
Q1
$8.43K Sell
56
-330
-85% -$49.7K ﹤0.01% 1323
2024
Q4
$71.3K Buy
386
+1
+0.3% +$185 ﹤0.01% 913
2024
Q3
$75.8K Sell
385
-10,060
-96% -$1.98M ﹤0.01% 877
2024
Q2
$2.16M Sell
10,445
-6,995
-40% -$1.45M 0.05% 254
2024
Q1
$4.73M Sell
17,440
-179
-1% -$48.5K 0.11% 168
2023
Q4
$4.17M Sell
17,619
-696
-4% -$165K 0.1% 176
2023
Q3
$3.59M Sell
18,315
-6,136
-25% -$1.2M 0.1% 179
2023
Q2
$5.14M Buy
24,451
+13,885
+131% +$2.92M 0.14% 141
2023
Q1
$2.13M Sell
10,566
-2,690
-20% -$543K 0.06% 234
2022
Q4
$2.89M Buy
13,256
+8,100
+157% +$1.77M 0.08% 202
2022
Q3
$1.02M Buy
5,156
+4,500
+686% +$886K 0.03% 337
2022
Q2
$140K Sell
656
-70
-10% -$14.9K ﹤0.01% 833
2022
Q1
$206K Sell
726
-9,779
-93% -$2.77M 0.01% 770
2021
Q4
$3.96M Sell
10,505
-7,580
-42% -$2.86M 0.09% 190
2021
Q3
$7.46M Sell
18,085
-2,431
-12% -$1M 0.19% 115
2021
Q2
$7.59M Sell
20,516
-330
-2% -$122K 0.2% 117
2021
Q1
$6.04M Sell
20,846
-1,710
-8% -$496K 0.17% 135
2020
Q4
$5.64M Sell
22,556
-230
-1% -$57.5K 0.18% 145
2020
Q3
$5.16M Sell
22,786
-15,930
-41% -$3.61M 0.2% 119
2020
Q2
$6.75M Sell
38,716
-23,520
-38% -$4.1M 0.28% 89
2020
Q1
$7.86M Buy
62,236
+4,140
+7% +$523K 0.36% 74
2019
Q4
$8.88M Sell
58,096
-14
-0% -$2.14K 0.33% 89
2019
Q3
$7.69M Buy
58,110
+11,400
+24% +$1.51M 0.34% 93
2019
Q2
$9.28M Buy
+46,710
New +$9.28M 0.42% 83